Home › Therapeutic areas › Metabolic › Mucopolysaccharidosis Type IIIB
Mucopolysaccharidosis Type IIIB (1 companies)
Companies with an active program in Mucopolysaccharidosis Type IIIB.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| SPRB | Spruce Biosciences | Metabolic Rare | 1 | Preclinical | $134M | 2 |
No companies match.